Facebook Twitter RSS Feed
 - face

Participants enrolled in cardiovascular clinical trials may be a poor representation of patients with MI, according to an analysis published Aug. 27 in JAMA. Researchers found enrollees generally to be healthier, younger and have a better prognosis than eligible nonparticipants.

 - aspirin

Venous thromboembolism (VTE) risks in patients taking aspirin were significantly reduced over nontreatment in a study published online Aug. 25  in Circulation.

 - Weighing Options

Novel oral anticoagulants have outstripped warfarin for usage in the U.S., but at a price. A study found that the three new options for treating patients with atrial fibrillation made up 62 percent of new prescriptions but cost $900 higher than warfarin after six months.

 - patient managment, blood pressure

The best way to reduce a patient’s blood pressure may be by getting the patient more involved. Hypertension patients not only effectively self-managed, but saw a greater reduction in mean blood pressure compared to those who did not, according to a study published in the Aug. 27 issue of JAMA.

 - doctor consulting patient computer

Joint PCI decision-making may be a best practice, but it appears physicians aren’t encouraging it through their communication styles, according to a paper published online Aug. 25 in JAMA: Internal Medicine.